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Bone Morphogenetic Proteins (BMPs) are key regulators of skeletal development. In this issue of Develop-
mental Cell, Zhou et al. show that neogenin, a receptor for neuronal axon guidance, also regulates endochon-
dral bone formation and BMP signaling and does so by influencing BMP receptor localization in membrane
microdomains.The formation of long bones during skel-
etal development occurs by endochon-
dral ossification, in which the embryonic
cartilage template is replaced by bone
in an intricate process involving chondro-
cyte proliferation, hypertrophy, and apo-
ptosis (Kronenberg, 2003). The cartilage
extracellular matrix, formed by chondro-
cytes, is then invaded by blood vessels,
osteoclasts, bonemarrow cells, and oste-
oblasts that deposit and continuously
remodel mineralized bone. This process
is tightly regulated by a plethora of extra-
cellular factors, including parathyroid
hormone related protein (PTHrP), Indian
hedgehog (Ihh), fibroblast growth factor
(FGF), Wnts, and Bone Morphogenetic
Proteins (BMPs) (Kronenberg, 2003).
BMPs are members of the Transforming
Growth Factor b (TGFb) superfamily and
are key regulators of bone formation.
In the BMP Smad pathway, BMP type I
and type II serine/threonine kinase recep-
tors recruit and phosphorylate receptor-
regulated Smad transcriptional modula-
tors (R-Smad1, 5, and 8). These activated
R-Smads form a complex with Smad4
and accumulate in the nucleus, where
they regulate gene transcription (Attisano
and Wrana, 2002; Moustakas and Heldin,
2009). As implied by their moniker, BMPs
have a long and storied history in the field
of bone development. BMPs are master
regulators of chondrogenesis and osteo-
blastogenesis, and mutations in either
BMPs or their receptors result in aberrant
chondrogenesis in mice (Song et al.,
2009).
Now enter neogenin, a member of the
Deleted in Colorectal Cancer (DCC) family
of axon guidance receptors. Neogenin
binds netrins and Repulsive GuidanceMolecules (RGMs) to regulate neuronal
morphogenesis, functions that would
seem far removed from bone (Cole et al.,
2007; De Vries and Cooper, 2008).
However, in this issue of Developmental
Cell, Zhou et al. report the surprising
finding that neogenin is required for BMP
signaling during chondrogenesis and
skeletal development (Zhou et al., 2010).
Intriguingly, they show that neogenin
mutant mice display defects in digit and
limb development and endochondral
ossification with reduced chondrocyte
hypertrophy, angiogenesis, and osteo-
blast invasion. Chondrocytes isolated
from neogenin mutant mice exhibited
reduced matrix deposition, impaired
chondrocyte differentiation, and defective
expression of several genes associated
with chondrocyte maturation. As men-
tioned above, BMPs play a key role in
skeletal development, and focused anal-
ysis revealed that neogenin-deficient
chondrocytes display reduced expres-
sion of BMP target genes and defective
BMP2-induced activation of the R-Smad
intracellular signaling mediators, both in
cultured cells and in mice. These results
reveal a critical role for neogenin in
promoting chondrogenesis in vitro and
in vivo, and uncover a novel and unex-
pected role for neogenin in the regula-
tion of BMP signaling during skeletal
development.
Regulation of BMP signaling by neoge-
nin is not as far-fetched as it may
first appear. As a member of the netrin-
binding DCC family, neogenin first
received attention for its role as a netrin
receptor that functions in axon guidance
(Cole et al., 2007; De Vries and Cooper,
2008). However, neogenin also bindsDevelopmental Cmembers of the RGM family (Severyn
et al., 2009). RGMs are glycosylphospha-
tidylinositol (GPI)-anchored proteins com-
posed of three members: RGMa, RGMb
(or DRAGON), and RGMc (or hemojuve-
lin/hemochromatosis type 2; HFE2).
Each RGM displays a distinct pattern of
expression, and though the physiological
functions are not yet fully understood, it
is known that the RGM biological reper-
toire includes repulsive axon guidance,
neuronal survival, and in the case of
RGMc, the regulation of systemic iron
metabolism (Severyn et al., 2009). Neoge-
nin has been implicated in several of these
RGM-mediated pathways, but of partic-
ular interest here, RGMs have been
directly linked to BMP signaling. Indeed,
RGMb was shown to directly bind certain
BMPs, to associate with BMP type I and
type II receptors, and to increase cell
responsiveness to BMPs (Samad et al.,
2005), an observation that has now been
extended to other RGM family members
(Severyn et al., 2009).
The work from Zhou et al. nicely dove-
tails with these prior studies. Specifically,
the authors show that RGMs, which
interact with both neogenin and BMP
receptors, act as protein bridges that
lead to the formation of a BMP receptor
supercomplex consisting of BMP recep-
tors, RGMs, and neogenin. So, what is
the purpose of this supercomplex? Cell
plasma membranes are composed of
membrane microdomains or lipid rafts
that are thought to serve as platforms to
segregate membrane components and
thereby control various physiological pro-
cesses, including signal transduction
(Simons and Toomre, 2000). Analysis
of neogenin-deficient chondrocytes byell 19, July 20, 2010 ª2010 Elsevier Inc. 1
Figure 1. A Model for BMP Signaling in Lipid
Rafts
Neogenin promotes lipid raft localization of BMP
receptors through direct interactions with the inter-
mediary RGM proteins and thereby promotes acti-
vation of the BMP-regulated R-Smads.
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receptors in lipid rafts were diminished,
and that this paralleled a reduction in
R-Smad activation. This would indicate
that optimal Smad activation requires
the localization of BMP receptors in lipid
rafts. Thus, Zhou et al. propose an
exciting model wherein neogenin facili-
tates BMP/Smad signaling by enhancing2 Developmental Cell 19, July 20, 2010 ª201lipid raft localization of BMP receptors
and RGMs provide the physical link
between neogenin and the BMP recep-
tors (Figure 1). One key question now is
how neogenin promotes RGM and BMP
receptor localization into lipid raft com-
partments. One possibility is that the
interaction between RGMs and BMP
receptors in lipid rafts may be stabilized
by neogenin and thus lead to enhanced
BMP signaling. Neogenin might also be
required for directing RGMs and BMP
receptors into lipid rafts. Although Smad
activation required neogenin, the authors
report that Smad-independent, BMP-
induced activation of p38 MAPK did not.
An understanding of the molecular basis
for this difference will also require future
attention.
Neogenin is a multifunctional receptor
binding both netrins and RGMs, yet sig-
naling pathways activated by neogenin
are poorly understood. The novel role of
neogenin in promoting lipid raft localiza-
tion of RGMs and BMP receptors during
endochondral bone formation reveals an
additional layer of complexity of neoge-
nin-mediated signaling and raises addi-
tional intriguing questions. In addition to
BMP receptors, does neogenin recruit
other protein partners into lipid rafts to
regulate neuronal or nonneuronal cell
activities? How ubiquitous is the require-
ment for neogenin in the multitude of0 Elsevier Inc.known BMP-dependent processes? Do
the pathways that neogenin regulates
in skeletal development also act in axon
guidance? This study provides an impor-
tant advance that has opened up
numerous exciting avenues for future
investigation, which will undoubtedly
help unravel the mysteries of BMP sig-
naling and neogenin.
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